Stockreport

Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update

Biofrontera Inc.  (BFRI) 
PDF Woburn, MA, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of derm [Read more]